Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.63 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.56 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.52 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22759956 | 1.00 | HPGD (0.64) | HPGDTAS1R3TAS1R1KDM4EPAX8 | |
| SCHEMBL19493330 | 1.00 | HPGD (0.64) | HPGDTAS1R3TAS1R1KDM4EPAX8 | |
| SCHEMBL12714694 | 1.00 | HPGD (0.64) | HPGDTAS1R3TAS1R1KDM4EPAX8 | |
| SCHEMBL15588761 | 1.00 | HPGD (0.64) | HPGDTAS1R3TAS1R1KDM4EPAX8 | |
| SCHEMBL7156480 | 1.00 | HPGD (0.64) | HPGDTAS1R3TAS1R1KDM4EPAX8 | |
| SCHEMBL235639 | 1.00 | HPGD (0.64) | HPGDTAS1R3TAS1R1KDM4EPAX8 | |
| SCHEMBL235638 | 1.00 | HPGD (0.64) | HPGDTAS1R3TAS1R1KDM4EPAX8 | |
| SCHEMBL19485507 | 1.00 | HPGD (0.64) | HPGDTAS1R3TAS1R1KDM4EPAX8 | |
| Water SCHEMBL29037307 | 0.99 | HPGD (0.63) | HPGDTAS1R3TAS1R1KDM4EPAX8 | |
| SCHEMBL23425454 | 0.94 | KDM4E (0.59) | HPGDTAS1R3TAS1R1KDM4EPAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200291096-A1 | BICYCLIC PEPTIDE LIGAND STING CONJUGATES AND USES THEREOF | Bicyclerd Limited (GB) | 2020-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200291096-A1 | BICYCLIC PEPTIDE LIGAND STING CONJUGATES AND USES THEREOF | STING1, BID, VIP | HPGD 3277/4885TAS1R3 490/4885TAS1R1 691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.